Gift supports research, training, community education programs, and clinic services for psychedelic therapy
WAYNESVILLE, N.C., Oct. 25, 2023 /PRNewswire/ — The Pearl Psychedelic Institute (“The Pearl”), a 501c3 nonprofit organization which aims to bring psychedelic-assisted therapy into mainstream practice through research, treatment, and training while reducing the barriers to patient access, today announced that it was awarded a $265,500 one-year grant from the Steven & Alexandra Cohen Foundation.
The grant will help to fund operating and treatment costs for the Pearl’s programs and clinic in Western North Carolina.
About The Pearl Psychedelic Institute
The primary goal of The Pearl is to advance the study and legalization of psychedelic medicine for the treatment of mental health issues in a safe and nurturing environment. Psychedelic medicine is at the forefront of research as a breakthrough in the treatment of many pressing mental health issues, including depression and Post Traumatic Stress Disorder (PTSD). The Pearl Psychedelic Institute has been approved by the Multidisciplinary Association of Psychedelic Studies (MAPS) as one of its nationwide site participants in the Food & Drug Administration’s (FDA) Expanded Access program utilizing MDMA as an adjunct in the treatment of treatment-resistant PTSD.
In addition to participating in cutting edge research studies, the Pearl currently offers training opportunities for therapists, wellness advocates, community partners and interested medical professionals on treating and understanding the use of psychedelics as a medicine for mental health and well-being. The clinic’s therapy psychedelic integration services are offered at a sliding scale fee schedule and use donor funds to offset patient costs.
SOURCE The Pearl Psychedelic Institute
